Eli Lilly's new experimental weight loss drug retatrutide yielded up to 28% weight loss, which is greater than that of ...

Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.

Lilly said people on the next-generation weight loss medication across three different dosages achieved weight loss of 19% to ...

Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a ...

New-generation GLP-1 drugs, such as retatrutide, are achieving higher rates of weight loss. How much weight is too much and too fast to lose?

In a clinical trial, the new weight-loss medication retatrutide led to "clinically meaningful weight reduction," with the ...

New study finds bariatric surgery may deliver five times greater long-term weight loss than Ozempic and other GLP-1 ...

Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded ...

While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three ...

Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under ...

The injection, called retatrutide, led to more weight loss than Zepbound did in clinical trials A view of the New York Stock Exchange after Eli Lilly's team rang the opening bell in New York on May 11 ...

Research suggests another side effect of weight loss drugs could be changing the brain - Scientists are looking to see how ...